Monz takes over as ceo of Carl Zeiss Meditec

Ludwin Monz has been named as chief executive of Carl Zeiss Meditec.

Ludwin Monz has been named as chief executive of Carl Zeiss Meditec. He takes over from Michael Kaschke, who resumes his role as chairman of the company's supervisory board.

Monz has been a member of Carl Zeiss Meditec's management board since October 2007 and is responsible for the firm's Ophthalmological Systems division. Prior to this he led the Microsurgery division for six years.

With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000.

You may also like

Digital
Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations

Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations

The digital data fabric links R&D, analytical development and GMP manufacturing, replacing periodic reporting with continuous audit-ready transparency aligned to FDA, EMA and PMDA expectations
Digital
TXP secures £1.5m MHRA contract for cloud architecture and cyber security services

TXP secures £1.5m MHRA contract for cloud architecture and cyber security services

The deal extends TXP's existing MHRA partnership, supporting the regulatory agency's digital modernisation through infrastructure development and knowledge transfer as TXP expands its UK public sector footprint
Digital
Camgenium launches pre-certified Foundation Platform for connected medical device development

Camgenium launches pre-certified Foundation Platform for connected medical device development

The infrastructure combines IEC 62304-compliant firmware, ISO 27001 cloud hosting and automated regulatory reporting, letting OEM teams focus engineering effort on clinical differentiation rather than compliance build-out
Digital
ZoBio launches integrated DEL hit discovery service for challenging drug targets

ZoBio launches integrated DEL hit discovery service for challenging drug targets

The new library-agnostic platform combines DEL screening with X-ray crystallography, quantitative biophysics and off-DNA validation, delivering structurally characterised, progressible starting points beyond conventional hit identification
Digital
Sapio Sciences and ZS partner to digitise biopharma R&D and CMC laboratories

Sapio Sciences and ZS partner to digitise biopharma R&D and CMC laboratories

The collaboration pairs Sapio's AI lab informatics platform with ZS's life sciences consulting expertise, delivering end-to-end ELN and LIMS deployment across regulated R&D and CMC environments
Digital
Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery

Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery

The company has introduced its new Biacore 8S and 8S+ surface plasmon resonance systems, combining high-throughput screening, molecular characterisation and automated workflows to support faster and more confident drug discovery
Digital
ByteSnap Design and Digi International partner to deliver SBOM-driven cybersecurity compliance for medical devices

ByteSnap Design and Digi International partner to deliver SBOM-driven cybersecurity compliance for medical devices

ByteSnap Design has announced a collaboration with Digi International to offer a managed security service for connected medical and industrial IoT devices to support compliance with FDA cybersecurity mandates and the EU Cyber Resilience Act
Subscribe now